HK1171011A1 - Sulfone derivative - Google Patents

Sulfone derivative

Info

Publication number
HK1171011A1
HK1171011A1 HK12111666.6A HK12111666A HK1171011A1 HK 1171011 A1 HK1171011 A1 HK 1171011A1 HK 12111666 A HK12111666 A HK 12111666A HK 1171011 A1 HK1171011 A1 HK 1171011A1
Authority
HK
Hong Kong
Prior art keywords
sulfone derivative
sulfone
derivative
Prior art date
Application number
HK12111666.6A
Other languages
English (en)
Inventor
Shigeo Yamanoi
Hidenori Namiki
Takahiro Katagiri
Mayuko Akiu
Katsuji Kagechika
Takeshi Honda
Koji Matsumoto
Ryutaro Nakashima
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of HK1171011A1 publication Critical patent/HK1171011A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C07D271/07—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK12111666.6A 2009-08-05 2012-11-16 Sulfone derivative HK1171011A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009182721 2009-08-05
PCT/JP2010/063150 WO2011016470A1 (fr) 2009-08-05 2010-08-04 Dérivé de sulfone

Publications (1)

Publication Number Publication Date
HK1171011A1 true HK1171011A1 (en) 2013-03-15

Family

ID=43544365

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12111666.6A HK1171011A1 (en) 2009-08-05 2012-11-16 Sulfone derivative

Country Status (11)

Country Link
US (1) US8754112B2 (fr)
EP (1) EP2468737B1 (fr)
JP (1) JP5546543B2 (fr)
KR (1) KR20120051668A (fr)
CN (1) CN102548977B (fr)
BR (1) BR112012002293A2 (fr)
CA (1) CA2770405C (fr)
ES (1) ES2439801T3 (fr)
HK (1) HK1171011A1 (fr)
TW (1) TWI452045B (fr)
WO (1) WO2011016470A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2585765C2 (ru) 2010-10-14 2016-06-10 Дайити Санкио Компани, Лимитед Производные ацилбензола
IN2014MN01442A (fr) * 2012-01-18 2015-07-03 Daiichi Sankyo Co Ltd
WO2018224455A1 (fr) 2017-06-07 2018-12-13 Basf Se Dérivés de cyclopropyle substitués

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0906310A4 (fr) * 1996-06-07 1999-09-01 Merck & Co Inc BENZENESULFONAMIDES D'OXADIAZOLE EN TANT QU'AGONISTES -g(b) 3? SELECTIFS POUR LE TRAITEMENT DU DIABETE ET DE L'OBESITE
CN1898235A (zh) 2003-12-24 2007-01-17 普罗西迪恩有限公司 作为gpcr受体激动剂的杂环衍生物
DE602004004631D1 (de) * 2004-04-01 2007-03-22 Sanofi Aventis Deutschland Oxadiazolone, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Pharmazeutika
PE20060362A1 (es) * 2004-05-24 2006-05-15 Irm Llc Compuestos de oxazol como moduladores de ppar
EP1623983A1 (fr) * 2004-08-05 2006-02-08 Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft Composés hétérocycliques utilisables comme inhibiteurs de DPP-IV
EP1907383A1 (fr) 2005-06-30 2008-04-09 Prosidion Limited Agonistes du gpcr
CA2613235A1 (fr) 2005-06-30 2007-01-11 Prosidion Limited Agonistes de gpcr
GB0606913D0 (en) * 2006-04-06 2006-05-17 Prosidion Ltd Compounds
US20090221639A1 (en) * 2006-04-06 2009-09-03 Lisa Sarah Bertram Heterocyclic GPCR Agonists

Also Published As

Publication number Publication date
EP2468737A4 (fr) 2013-01-23
EP2468737B1 (fr) 2013-10-30
TWI452045B (zh) 2014-09-11
CA2770405C (fr) 2015-03-17
WO2011016470A1 (fr) 2011-02-10
BR112012002293A2 (pt) 2016-06-14
CN102548977A (zh) 2012-07-04
TW201109322A (en) 2011-03-16
CN102548977B (zh) 2014-07-23
US8754112B2 (en) 2014-06-17
JP5546543B2 (ja) 2014-07-09
EP2468737A1 (fr) 2012-06-27
KR20120051668A (ko) 2012-05-22
JPWO2011016470A1 (ja) 2013-01-10
CA2770405A1 (fr) 2011-02-10
ES2439801T3 (es) 2014-01-24
US20120129891A1 (en) 2012-05-24

Similar Documents

Publication Publication Date Title
EP2420493A4 (fr) Dérivés d'haloalkylsulfonanilide
HK1173142A1 (en) N1-sulfonyl-5-fluoropyrimidinone derivatives n1--5-
HK1172893A1 (en) 5-fluoropyrimidinone derivatives 5-
IL219087A0 (en) Benzimidazole-imidazole derivatives
EP2397480A4 (fr) Dérivé de diazépinedione
IL216007A0 (en) Isoxazole-pyridine derivatives
PL2433940T3 (pl) Pochodna spiroimidazolonu
IL215109A0 (en) Isoxazole-pyridazine derivatives
IL214941A0 (en) Isoxazole-pyrazole derivatives
IL213927A0 (en) Deoxyactagardine derivatives
EP2401281A4 (fr) Dérivé de pyrimido-pyrimido-indazole
HK1172894A1 (en) N1-acyl-5-fluoropyrimidinone derivatives n1--5-
HK1169623A1 (en) Pyrazinooxazepine derivatives
HK1174621A1 (en) 5-hydroxypyrimidine-4-carboxamide derivative 5--4-
EP2476682A4 (fr) Dérivés de 8-oxodihydropurine
EP2463290A4 (fr) Dérivé de thiénooxazépine
HK1171011A1 (en) Sulfone derivative
EP2512482A4 (fr) Dérivés de 2-aldoximino-5-fluoropyrimidine
IL213262A0 (en) Tetrahydronaphthalen-2-ol derivatives
GB0912499D0 (en) Indopyl-pyridone derivatives
EP2497764A4 (fr) Dérivé de diphénylnaphtylamine

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170804